» Articles » PMID: 10322099

Induced Sputum for the Investigation of Airway Inflammation: Evidence for Its Clinical Application

Overview
Journal Can Respir J
Publisher Wiley
Specialty Pulmonary Medicine
Date 1999 May 13
PMID 10322099
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Airway inflammation is considered to be the primary cause of airway diseases. Its prevention and reversal are the primary aims of treatment. Measurement of the inflammation is now possible relatively noninvasively and reliably by using induced sputum cell counts. The differential count indicates the presence and type of the inflammation (eosinophilic or neutrophilic) and the total cell count the intensity. Sputum eosinophilia responds to treatment with corticosteroid, while there is increasing evidence that an isolated neutrophilia does not. Clinical judgement of airway inflammation is made difficult because of the different types of inflammation and their inconsistent correlation with the clinical features. Hence, reliable measurement of induced sputum cell counts may be useful to guide treatment in clinical practice. Consideration should now be given as to how to make it more available.

Citing Articles

Small airways dysfunction in asthma: evaluation and management to improve asthma control.

Usmani O Allergy Asthma Immunol Res. 2014; 6(5):376-88.

PMID: 25228994 PMC: 4161678. DOI: 10.4168/aair.2014.6.5.376.


Biomarkers to assess the utility of potential reduced exposure tobacco products.

Hatsukami D, Benowitz N, Rennard S, Oncken C, Hecht S Nicotine Tob Res. 2006; 8(4):600-22.

PMID: 16920658 PMC: 6615727. DOI: 10.1080/14622200600858166.


Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.

Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D Thorax. 2002; 57(4):309-16.

PMID: 11923548 PMC: 1746305. DOI: 10.1136/thorax.57.4.309.